Argos Therapeutics Presents Data Showing Memory T Cell Expansion After …

Published November 11, 2013

Argos Therapeutics Presents Data Showing Memory T Cell Expansion After …
The randomized, multicenter, open-label ADAPT clinical trial is designed to examine the potential for AGS-003 plus standard targeted drug therapy to extend OS versus standard therapy alone in newly diagnosed mRCC patients. Argos is using BTSVQ to … Read more on EIN News (press release)

MacroGenics DART Therapeutic Selected by Boehringer Ingelheim as a Bi …
Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics, added: "We are pleased that the lead candidate in this research program achieved this milestone. Over the past three years, we have greatly enjoyed our relationship with Boehringer Ingelheim … Read more on GlobeNewswire (press release)

State's first veterans' court may launch in Prince George's
Funding pends approval of the application and would be mostly federal, with the U.S. veterans department covering all rehabilitation and treatment programs, Peters said. Remaining costs would be covered by the state and county. The number of veterans … Read more on Gazette.Net: Maryland Community News Online